<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Severe <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> associated with <z:mp ids='MP_0002055'>diabetes</z:mp> management is a potential risk for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the effect and mechanism of <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> on the progression of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> remains largely unknown </plain></SENT>
<SENT sid="2" pm="."><plain>As a first step towards elucidating the above, we investigated the effect of <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> on monocyte-endothelial interaction </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Insulin was injected intraperitoneally once every 3 days for 5 weeks in Goto-Kakizaki rats, a non-<z:mp ids='MP_0001261'>obese</z:mp> rat model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>We counted the number of monocytes adherent to the endothelium of thoracic aorta as an index of early atherosclerogenesis </plain></SENT>
<SENT sid="5" pm="."><plain>Cultured HUVEC were used to investigate the mechanism of action </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Insulin treatment increased the number of monocytes adherent to the vascular endothelium </plain></SENT>
<SENT sid="7" pm="."><plain>This increase was abrogated by injection of <z:chebi fb="105" ids="17234">glucose</z:chebi> with insulin </plain></SENT>
<SENT sid="8" pm="."><plain>Amosulalol, an α-1 and β-adrenoreceptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, suppressed monocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to endothelium and levels of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules (intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 and vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1) in the endothelial surface, which had been enhanced by insulin-induced <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>In HUVEC, <z:chebi fb="47" ids="28918,33568">adrenaline</z:chebi> (<z:chebi fb="2" ids="28918">epinephrine</z:chebi>) significantly increased nuclear translocation of nuclear factor-κB (NF-κB) p65 and levels of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules, effects that were abrogated following addition of SQ22536, a specific adenyl cyclase inhibitor </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: Our data indicate that repetitive <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> induced by insulin enhanced monocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to endothelial cells in Goto-Kakizaki rat aorta through enhanced <z:chebi fb="47" ids="28918,33568">adrenaline</z:chebi> activity and that the latter stimulated intracellular cAMP, leading to nuclear translocation of NF-κB with subsequent production of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules in endothelial cells </plain></SENT>
</text></document>